Geron Corp (GERN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows some positive trends, such as hedge fund buying and slight improvements in financials, the lack of significant positive catalysts, neutral technical indicators, and a recent price target downgrade suggest that holding off on a purchase is prudent. The stock does not currently present a compelling entry point.
The technical indicators are mixed. The MACD is above zero but contracting, indicating weakening bullish momentum. The RSI is neutral at 50.9, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading below its pivot point of 1.716, with key support at 1.62 and resistance at 1.811.

Hedge funds are significantly increasing their positions, with a 226.92% increase in buying over the last quarter. The company's revenue and net income have shown slight YoY improvements in Q4 2025.
No recent news or significant insider activity. Analysts have lowered the price target from $4 to $3, reflecting reduced optimism. Gross margin has slightly declined YoY. The stock has no recent AI Stock Picker or SwingMax signals.
In Q4 2025, revenue increased by 1.01% YoY to $48,015,000, and net income improved by 13.85% YoY to -$28,862,000. EPS remained unchanged at -0.04, while gross margin dropped slightly to 97.28%, down 1.09% YoY.
TD Cowen analyst Tara Bancroft maintains a Buy rating but has lowered the price target from $4 to $3, indicating tempered expectations for the stock's performance.